Viewing Study NCT06494332



Ignite Creation Date: 2024-07-17 @ 10:42 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06494332
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2024-07-02

Brief Title: Prevention of Lateral Epicondylalgia in Handgun Olympic Shooting Athletes
Sponsor: University of Valencia
Organization: University of Valencia

Study Overview

Official Title: Effect of Exercise Combined With Stretching Program to Prevent Lateral Epicondylalgia in Handgun Olympic Shooting Athletes a Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Lateral epicondylalgia is one of the most common pathologies suffered by Olympic gun shooting athletes In Spain there is hardly any research carried out in this sport so there are no injury prevention protocols available Preventing these injuries would be fundamental to improve the performance of athletes and to be able to continue adding successes to national honors

It has also been evidenced that if exercise is combined with stretching the benefits of physical therapy are increased High-quality studies have stated that it is not necessary for this exercise protocol combined with stretching to be very prolonged over time as they affirm that significant improvements can be achieved with only four weeks of exercise

This study aimed to test the hypothesis that Olympic handgun shooting athletes who perform a four-week multimodal exercise program combined with stretching have a lower risk of suffering from lateral epicondylalgia than athletes who do not perform this program determining its effectiveness for pain prevention
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None